إعلان
إعلان

SKYE

SKYE logo

Skye Bioscience, Inc. Common Stock

0.98
USD
برعاية
-0.07
-6.76%
٠٩ يناير, ١٥:٥٢ UTC -5
مغلق
exchange

بعد الإغلاق

1.00

+0.02
+1.84%

تقارير أرباح SKYE

النسبة الإيجابية المفاجئة

SKYE تفوق 5 من 9 آخر التقديرات.

56%

التقرير التالي

بيانات التقرير القادم
١٨ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.30
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-6.25%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
+25.00%

Skye Bioscience, Inc. Common Stock earnings per share and revenue

On ١٠ نوفمبر ٢٠٢٥, SKYE reported earnings of -0.32 USD per share (EPS) for Q3 25, beating the estimate of -0.33 USD, resulting in a 5.66% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.82% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 المحللين forecast an EPS of -0.30 USD, with revenue projected to reach -- USD, implying an نقصان of -6.25% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Skye Bioscience, Inc. Common Stock reported EPS of -$0.32, beating estimates by 5.66%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.82%, changed from $1.42 before the earnings release to $1.46 the day after.
The next earning report is scheduled for ١٨ مارس ٢٠٢٦.
Based on 10 المحللين, Skye Bioscience, Inc. Common Stock is expected to report EPS of -$0.30 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان